Event : Three Key Aspects of Risk Management during Phase 3 Clinical Trials http://www.rsc.org/events/detail/1262/Three%20Key%20Aspects%20of%20Risk%20Management%20during%20Phase%203%20Clinical%20Trials This is a feed for event : Three Key Aspects of Risk Management during Phase 3 Clinical Trials Thu, 11 Sep 2014 13:13:13 +0100 1262 1262 http://www.rsc.org/events/detail/1262/Three%20Key%20Aspects%20of%20Risk%20Management%20during%20Phase%203%20Clinical%20Trials Three Key Aspects of Risk Management during Phase 3 Clinical Trials Event dates: 23 April 2008<br/>Event summary: Risk Minimization Action Plans (Risk MAPs) evolve as clinical and safety data emerge in a product’s lifecycle. Risk MAPs should begin to be developed as early in the product life cycle as possible, <br/>Event Venue: Online, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00